Inhibition of the VEGFR-2 tyrosine kinase domain by witd Roman chamomile extracts and phenolic compounds
Artigo de Conferência
Visão geral
Visão geral
resumo
Angiogenesis results from new blood vessels growing excessively (e. g. câncer). The Vascular
Endothelial Growth Factor (VEGF) is secreted by the tumor cells and plays a crucial role in
angiogenesis; low oxygen tension dramatically induces the expression of this major angiogenic
factor that when linked to the transmembrane tyrosine kinase receptor VEGFR-2, which is
present in endothelial cells, signalizes for the proliferation of these cells towards the tumor.
Treatments using small molecules with anti-tyrosine kinase activity (e. g., sorafenib) can block
angiogenic signalling, reduce blood tumoral irrigation, and improve chemotherapy distribution
[1]. Some studies recognized phenolic compounds as chemopreventive agents, especially
flavonoids. Other plant-derived anticancer drugs (e. g. Taxol) proved to be anti-angiogenic. In
traditional Chinese medicine, many herbs are used in the treatment of angiogenic diseases
such as chronic wounds and rheumatoid arthritis [2]. Furthermore, it has been reported that
drinking of green tea could inhibit VEGF-induced angiogenesis in vivo [3]. In the present work,
the anti-angiogenic activity of Roman chamomile (Chamaemelum nobile L.) extracts (methanolic
extract and infusion) and main phenolic compounds (apigenin, apigenin-7-O-glucoside, caffeic
acid, chlorogenic acid, luteolin, luteolin-7-O-glucoside) was evaluated through an enzymatic
assay using the VEGFR-2 tyrosine kinase domain. To better understand the inhibition
phosphorylation mechanism of the tyrosine kinase receptor by luteolin, apigenin and apigenin-7-
0-glucoside, docking studies were performed. The methanolic extract showed higher
phosphorylation inhibition than the infusion (IC50 values of 269 and 301 μg/mL, respectively).
Regarding phenolic compounds, luteolin (IC50 2.10 μM) and apigenin (IC50 4.78 μM) were the
most potent in inhibiting VEGFR-2 phosphorylation, leading us to believe that these compounds
are involved in the anti-angiogenic activity revealed by the methanolic extract.